Literature DB >> 3916440

Compliance in hypertension: facts and concepts.

T F Lüscher, H Vetter, W Siegenthaler, W Vetter.   

Abstract

The management of hypertension is still far from optimal, although safe and effective drugs are available and the effectiveness of antihypertensive therapy in reducing cardiovascular morbidity is well established. Today, low patient compliance is one of the most important therapy-limiting factors in hypertension. Although patient care seems to have improved, possibly due to increased knowledge about patient compliance in recent years, 10-15% of hypertensives are still lost from follow-up in the first year of therapy, and 20-40% of patients comply insufficiently with prescribed antihypertensive therapy. In this article the magnitude of the problem of drop-outs and non-compliance with medication, the determinants of compliance in hypertension, and the models used to understand patients' health behaviour are reviewed.

Entities:  

Mesh:

Year:  1985        PMID: 3916440

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  16 in total

Review 1.  Pharmacoeconomics of hypertension management: the place of combination therapy.

Authors:  E Ambrosioni
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Measurement of patient compliance and the interpretation of randomized clinical trials.

Authors:  R Vander Stichele
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study.

Authors:  Scot H Simpson; Sumit R Majumdar; Ross T Tsuyuki; Dean T Eurich; Jeffrey A Johnson
Journal:  CMAJ       Date:  2006-01-17       Impact factor: 8.262

4.  Supporting self-care in general practice.

Authors:  Colin J Greaves; John L Campbell
Journal:  Br J Gen Pract       Date:  2007-10       Impact factor: 5.386

5.  Managing hypertension in general practice: a cross-sectional study of treatment and ethnicity.

Authors:  Peter Schofield; Frances Baawuah; Paul T Seed; Mark Ashworth
Journal:  Br J Gen Pract       Date:  2012-10       Impact factor: 5.386

6.  Patients' decisions about whether or not to take antihypertensive drugs: qualitative study.

Authors:  John Benson; Nicky Britten
Journal:  BMJ       Date:  2002-10-19

7.  Hypertension in multicultural and minority populations: linking communication to compliance.

Authors:  J R Betancourt; J E Carrillo; A R Green
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

8.  Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension.

Authors:  P Greminger; P M Suter; D Holm; R Kobelt; W Vetter
Journal:  Clin Investig       Date:  1994-11

9.  Compliance and the elderly hypertensive.

Authors:  T O Morgan; C Nowson; J Murphy; R Snowden
Journal:  Drugs       Date:  1986       Impact factor: 9.546

10.  Comparison of persistence rates of acetylcholine-esterase inhibitors in a state Medicaid program.

Authors:  Susan M Abughosh; Stephen J Kogut
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.